創益生技——守護國人健康的領導者
Chuang Yi Biotech — Leader in Safeguarding National Health
創益生技於1991年創立，源於藥業，
以守護國人基礎健康為核心價值。
從預防醫學，健康促進及小兒免疫出發，
致力於開發多元的保健產品，
如專利益生菌、有實證的保健食品、
高效細胞流感疫苗、藥品及醫材等。
我們深信，通過改善基礎健康，可以提升國人的生活品質 (QOL)。
期許為國人帶來全方位的健康解決方案！
以守護國人基礎健康為核心價值。
從預防醫學，健康促進及小兒免疫出發，
致力於開發多元的保健產品，
如專利益生菌、有實證的保健食品、
高效細胞流感疫苗、藥品及醫材等。
我們深信，通過改善基礎健康，可以提升國人的生活品質 (QOL)。
期許為國人帶來全方位的健康解決方案！
Founded in 1991 with roots in pharmaceuticals, Chuang Yi Biotech is dedicated to protecting the foundational health of the nation as its core value. Starting with preventive medicine, health promotion, and pediatric immunity, we are committed to developing diverse health products, including specialized probiotics, evidence-based health supplements, high-efficacy cellular influenza vaccines, pharmaceuticals, and medical devices. We firmly believe that improving foundational health can enhance the quality of life (QOL) for the public. Our aspiration is to provide comprehensive health solutions for all!
隨著2024年民眾生活恢復正常，面對市場的多元化成長與機遇
Embracing Diverse Market Growth and Opportunities
藥品保健產業逐步回升並成長，
醫藥產品及生技研發迎來更多元化契機。
創益生技產品線涵蓋醫療等級益生菌外，
疫苗、小兒過敏免疫、機能保健(胃腸保健、美體瘦身)等，
我們持續深耕藥通路，並進入流售市場帶來新的成長動力。
通過醫學研討會、衛教服務及社群推播，
建立正確醫療保健觀念，改善國人生活品質。
As lifestyles normalized in 2024, the pharmaceutical and health industry has seen steady recovery and growth, with diversified opportunities emerging in medical products and biotech research.
Beyond medical-grade probiotics, Chuang Yi Biotech’s product portfolio includes vaccines, pediatric allergy immunity, and functional health products (gastrointestinal health, body shaping, etc.). We continue to deepen our presence in pharmaceutical channels while entering retail markets to drive new growth. Through medical seminars, health education services, and social media engagement, we aim to establish proper healthcare awareness and improve the quality of life for the public.
一、掌握市場需求：經營政策與發展策略
Business Policies and Development Strategies
掌握消費者需求及市場保健脈動，
善用產品行銷經驗及醫療通路，
持續擴大產品功效領域及研發上市關聯性產品創造綜效。
1.Meeting Market Demand:
Understand consumer needs and market trends in healthcare, leveraging product marketing expertise and medical channels to expand product efficacy areas and develop related products for synergistic growth.
二、擴展通路：
積極擴張診所及藥局通路，
並進入地區醫院及新興零售通路，
結合自有產品的好口碑及商品客製化的彈性，達到雙贏合作。
2.Channel Expansion:
Actively expand clinic and pharmacy channels, enter regional hospitals and emerging retail channels, and leverage our strong product reputation and customized offerings for mutually beneficial partnerships.
三、強化客戶關係：
維持既有客戶，強化客戶關係，
推出適合兒童及家庭的保健產品，以提升營運動能。
3.Strengthening Customer Relationships:
Maintain existing customer bases, strengthen relationships, and launch health products tailored for children and families to boost operational momentum.
四、人才培育：
落實適才適所的管理職能，
並成立官方LinkedIn網頁增加公司及產品曝光，
及尋覓合適的合作夥伴為目標。
4.Talent Development:
Implement merit-based management, establish an official LinkedIn page to increase company and product visibility, and seek suitable partners for collaboration.
成為台灣及大中華地區，企業願景及使命
Corporate Vision and Mission
致力於研發/行銷生活品質改善類別(QOL)之自費藥品及保健產品之創新領導廠商。
To become a leading innovator in Taiwan and Greater China, dedicated to researching and marketing self-pay pharmaceuticals and health products that enhance quality of life (QOL).
Our mission includes:
我們的使命包括：
一、持續研發具特殊性之自費藥品
1.Continuously develop specialized self-pay pharmaceuticals.
二、藉臨床試驗及法規登記工作提升產品定位
2.Elevate product positioning through clinical trials and regulatory registrations.
三、深耕醫療通路，成為國際藥廠最佳合作夥伴
3.Deepen medical channel presence to become the preferred partner for international pharmaceutical companies.
應對挑戰，持續前行
Addressing Challenges and Moving Forward
.png)
近年，台灣因為新冠疫情衝擊，出生率降低，供應鏈的不穩定，
影響業績及新產品開發機會，短期難以改善。
In recent years, Taiwan has faced challenges such as declining birth rates due to the COVID-19 pandemic, supply chain instability, and limited opportunities for new product development, which are difficult to resolve in the short term.
上呼吸道健康需求大增，腸胃道問題普遍，
國人普遍認識到預防重於治療，
對生活品質改善類別(QOL)之自費藥品及保健食品需求持續增長。
Demand for upper respiratory health products has surged, gastrointestinal issues are prevalent, and the public increasingly recognizes that prevention is better than cure. The demand for self-pay pharmaceuticals and health supplements that improve quality of life (QOL) continues to grow.
綜上所述，創益生技秉持實證醫學精神，
持續提供高品質、高功效及特殊性的自費藥品及保健食品，
滿足國人健康需求，改善生活品質！
In summary, Chuang Yi Biotech upholds the spirit of evidence-based medicine, continuously providing high-quality, high-efficacy, and specialized self-pay pharmaceuticals and health supplements to meet national health needs and enhance quality of life!